SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: SeachRE5/21/2020 11:15:02 PM
1 Recommendation

Recommended By
pocotrader

   of 1576963
 
Less than two-thirds of Americans are "very" or "somewhat" interested in getting a COVID-19 vaccine if one becomes available, according to a Reuters/Ipsos poll released Thursday. About a quarter of those surveyed had little or no interest in taking a vaccine, Reuters reported, and more than 40% said the vaccine could be riskier than the disease. That's a disturbing number, as medical experts say about 70% of the population would need to be be immune, either through vaccine or by fending off a previous infection, for herd immunity to prevent the further spread of the coronavirus. The poll also found a troubling gap in credibility. While 29% of those "not very" interested in a vaccine said they would be more interested if it had FDA approval, 36% of overall respondents said they would be less inclined to take a vaccine if President Donald Trump said it's safe to do so, according to Reuters.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News